dihexa human trials status 2026 clinical dihexa clinical trials Umbrella Lab Announces Documentation And Traceability Update For Dihexa Peptide Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Getting Ready for the 2026 MDA Clinical & Scientific Conference Quest Muscular Dystrophy Association bpc 157 clinical studies human trials trial kpv bpc 157 tb500 dihexa human status 2026 SCOPE 2026, Simplified Patient Recruitment Management, AI A Look at Pennsylvania Clinical Trials in April 2026 Dihexa in Clinical Trials: What We've Learned So Far
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21



